| 股票代码 | 000739 | 当期评分 | ||||
| 股票名称 | 普洛药业 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | 0.7066 | 1.154 | 0.8476 | 0.8476 | 0.8476 | ✘ |
| 销售净利润率(%) | 5.8115 | 7.6747 | 10.8443 | 10.8443 | 10.8443 | ✘ |
| 销售毛利率(%) | 31.2038 | 31.7544 | 27.6389 | 27.6389 | 27.6389 | ✘ |
| 净资产收益率(%) | 11.08 | 14.69 | 14.99 | 14.99 | 14.99 | ✘ |
| 营业增长率(%) | 14.8536 | 13.0844 | 7.3012 | 7.3012 | 7.3012 | ✘ |
| 净利润增长率(%) | 44.4187 | 49.339 | 45.9912 | 45.9912 | 45.9912 | ✔ |
| 每股收益(%) | 0.3144 | 0.4696 | 0.5347 | 0.3644 | 0.1313 | ✔ |
| 现金流量比率(%) | 37.7862 | 53.0953 | 30.0889 | 18.6708 | 5.4055 | ✔ |
| 三项费用比重(%) | 19.9563 | 18.1163 | 12.3645 | 11.1826 | 13.6103 | ✔ |
| 每股净资产(¥) | 2.8377 | 3.1972 | 3.567 | 3.3966 | 3.3285 | ✔ |
| 流动比率(%) | 1.3952 | 1.5451 | 1.5686 | 1.4807 | 1.531 | ✔ |
| 速动比率(%) | 0.9863 | 1.1575 | 1.2591 | 1.2034 | 1.1793 | ✔ |
| 现金比率(%) | 29.2247 | 40.4367 | 72.9601 | 55.4797 | 55.4797 | ✔ |
| 总资产利润率(%) | 6.4774 | 9.0179 | 8.8434 | 6.0544 | 2.2766 | ✘ |
| 主营利润比重% | 430.483 | 361.3102 | 219.4131 | 218.4795 | 262.5785 | ✔ |
| 应收账款(万元) | 102,442.47 | 102,513.86 | 106,622.87 | 140,337.83 | 109,528.55 | ✔ |
| 应收票据(万元) | 21,081.30 | -- | -- | -- | -- | ✘ |
| 预付款项(万元) | 12,492.39 | 12,080.86 | 19,158.32 | 18,736.96 | 19,316.44 | ✘ |
| 存货(万元) | 90,101.84 | 99,304.30 | 102,772.64 | 95,791.27 | 104,071.22 | ✔ |
| 在建工程(万元) | 15,156.99 | 11,884.80 | 17,385.83 | 16,189.99 | 13,949.78 | ✘ |
| 应付款项(万元) | 79,129.20 | 108,629.38 | 115,691.37 | 129,129.37 | 111,988.71 | ✔ |
| 长期借款(万元) | -- | -- | -- | -- | -- | ✔ |
| 未分配利润(万元) | 161,961.01 | 201,884.45 | 245,450.66 | 225,385.94 | 217,357.79 | ✘ |
| 商誉(万元) | 2,950.44 | 2,031.01 | 2,031.01 | 2,031.01 | 2,031.01 | ✔ |
| 流动资产(万元) | 267,622.92 | 256,461.30 | 252,018.07 | 254,916.04 | 254,136.87 | ✘ |
| 流动负债(万元) | 220,369.67 | 256,155.52 | 331,997.20 | 345,474.40 | 295,844.70 | ✔ |
普洛药业000739评分结果 | 51.52分 | 卖出/减持 | ||||